| 中文同義詞: | CL2A-SN-38 二氯乙酸鹽;化合物CL2A-SN-38;4-((S)-2-(4-氨基丁基)-35-(4-((4-((2,5-二氧代-2,5-二氫-1H-吡咯-1-基)甲基)環(huán)己烷甲酰胺) 甲基)-1H-1,2,3-三唑-1-基)-4,8-二氧代-6,12,15,18,21,24,27,30,33-九氧雜-3,9-二氮雜三十五烷酰胺)芐基 ((S)-4,11-二乙基-9-羥基-3,14-二氧代-3,4,12,14-四氫-1H-吡喃并[3',4':6,7]吲哚并[1,2-B]喹啉-4-基)碳酸酯;CL2A|||CL2A SN 38|||BYSTANDER EFFECT|||SN-38|||ANTITUMOR|||CL2A-SN-38|||INHIBITOR|||DRUG-LINKER CONJUGATES FOR ADC|||INHIBIT|||DNA TOPOISOMERASE I|||ADC|||CL-2A-SN-38|||CL2ASN38;4-((S)-2-(4-氨基丁基)-35-(4-((4-((2,5-二氧代-2,5-二氫-1H-吡咯-1-基)甲基)環(huán)己烷甲酰胺) 甲基)-1H-1,2,3-三唑-1-基)-4,8-二氧代-6,12,15,18,21,24,27,30,33-九氧雜-3,9-二氮雜三十五烷酰胺)芐基 ((S)-4,11-二乙基-9-羥基-3,14-二氧代-3,4,12,14-四氫-1H-吡喃并[3',4':6,7]吲哚并[1,2-B]喹啉-4-基)碳酸酯(實為二氯乙酸鹽非游離態(tài));4-[[(2S)-2-(4-氨基丁基)-35-[4-[[[[4-[(2,5-二氫-2,5-二氧代-1H-吡咯-1-基)甲基]環(huán)己基]羰基]氨基]甲基]-1H-1,2,3-三氮唑-1-基]-1,4,8-三氧代-6,12,15,18,21,24,27,30,33-九氧雜-3,9-二氮雜五三ACONT-1-基]氨基]苯基]甲基 (4S)-4,11-二乙基-3,4,12,14-四氫-9-羥基-3,14-二氧代-1H-吡喃并[3',4':6,7]氮茚并[1,2-B]喹啉-4-基 碳酸鹽;4-((S)-2-(4-氨基丁基)-35-(4-((4-((2,5-二氧代-2,5-二氫-1H-吡咯-1-基)甲基)環(huán)己烷甲酰胺) 甲基)-1H-1,2,3-三唑-1-基)-4,8-二氧代-6,12,15,18,21,24,27,30,33-九氧雜-3,9-二氮雜三十五烷酰胺)芐基 ((S)-4,11-二乙基-9-羥基-3,14-二氧代-3,4,12,14-四氫-1H-吡喃并[3',4':6,7]吲哚并[1,2-b]喹啉-4-基)碳酸酯(實為二氯乙酸鹽非游離態(tài)) |
| 英文同義詞: | CL2A-SN-38;Carbonic acid, [4-[[(2S)-2-(4-aminobutyl)-35-[4-[[[[4-[(2,5-dihydro-2,5-dioxo-1H-pyrrol-1-yl)methyl]cyclohexyl]carbonyl]amino]methyl]-1H-1,2,3-triazol-1-yl]-1,4,8-trioxo-6,12,15,18,21,24,27,30,33-nonaoxa-3,9-diazapentatriacont-1-yl]amino]phenyl]methyl (4S)-4,11-diethyl-3,4,12,14-tetrahydro-9-hydroxy...;[4-[[(2S)-2-(4-Aminobutyl)-35-[4-[[[[4-[(2,5-dihydro-2,5-dioxo-1H-pyrrol-1-yl)methyl]cyclohexyl]carbonyl]amino]methyl]-1H-1,2,3-triazol-1-yl]-1,4,8-trioxo-6,12,15,18,21,24,27,30,33-nonaoxa-3,9-diazapentatriacont-1-yl]amino]phenyl]methyl(4S)-4,11-diethyl-3;4-[[(2S)-2-(4-Aminobutyl)-35-[4-[[[[4-[(2,5-dihydro-2,5-dioxo-1H-pyrrol-1-yl)methyl]cyclohexyl]carbonyl]amino]methyl]-1H-1,2,3-triazol-1-yl]-1,4,8-trioxo-6,12,15,18,21,24,27,30,33-nonaoxa-3,9-diazapentatriacont-1-yl]amino]phenyl]methyl(4S)-4,11-diethyl-3,4,12,14-tetrahydro-9-hydroxy-3,14-dioxo-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinolin-4-yl carbonate;4-((S)-2-(4-Aminobutyl)-35-(4-((4-((2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)methyl)cyclohexanecarboxamido)methyl)-1H-1,2,3-triazol-1-yl)-4,8-dioxo-6,12,15,18,21,24,27,30,33-nonaoxa-3,9-diazapentatriacontanamido)benzyl ((S)-4,11-diethyl-9-hydroxy-3,14-dioxo-3,4,12,14-tetrahydro-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinolin-4-yl) carbonate;4-[[(2S)-2-(4-Aminobutyl)-35-[4-[[[[4-[(2,5-dihydro-2,5-dioxo-1H-pyrrol-1-yl)methyl]cyclohexyl]carbonyl]amino]methyl]-1H-1,2,3-triazol-1-yl]-1,4,8-trioxo-6,12,15,18,21,24,27,30,33-nonaoxa-3,9-diazapentatriacont-1-yl]amino]phenyl]methyl (4S)-4,11-diethyl-3,4,12,14-tetrahydro-9-hydroxy-3,14-dioxo-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinolin-4-yl carbonate;{4-[(2S)-6-amino-2-(2-{[(26-{4-[({4-[(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)methyl]cyclohexyl}formamido)methyl]-1H-1,2,3-triazol-1-yl}-3,6,9,12,15,18,21,24-octaoxahexacosan-1-yl)carbamoyl]methoxy}acetamido)hexanamido]phenyl}methyl (19S)-10,19-diethyl-7-hydroxy-14,18-dioxo-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.0?,?.01?,2?]henicosa-1(21),2(11),3,5,7,9,15(20)-heptaen-19-yl carbonate |